PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
08-Feb-2024 Orexa Announces First Patient Dosed in Phase 2 Trial in Post-Operative Patients Orexa B.V.
07-Feb-2024 TRIAL OF NEW PSYCHEDELIC DRUG SEEKS PATIENTS WITH TREATMENT RESISTANT DEPRESSION Clerkenwell Health
07-Feb-2024 HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session HUTCHMED
07-Feb-2024 Invizius Treats First Patients in First-In-Human Phase 1 Clinical Study of Lead Dialysis Product H-Guard® Invizius
07-Feb-2024 Biocomposites announces two new Phase II clinical trials of STIMULAN VG - a calcium matrix antibiotic carrier mixed with vancomycin and gentamicin – in the U.S. Biocomposites
06-Feb-2024 Kancera presents the statistical analysis of top line data from the FRACTAL study Kancera
06-Feb-2024 Game-Changing ‘Audit Trail Review’ Application Secures ACDM 2024 Awards Nomination for CluePoints CluePoints
06-Feb-2024 Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001 Thermosome GmbH
05-Feb-2024 Breaking Boundaries in Medical Device Sterilization: 5th Edition Excellence Conference marcus evans
01-Feb-2024 NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline NeoPhore Limited
01-Feb-2024 Vivet Therapeutics receives EUR 4.9 million to advance development of a gene therapy for the treatment of cerebrotendinous xanthomatosis Vivet Therapeutics
01-Feb-2024 EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO EnteroBiotix
01-Feb-2024 Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health's Advisory Board Lindus Health
31-Jan-2024 Almirall and Microsoft announce partnership for digital transformation to enable the development of novel treatments for skin diseases Almirall
31-Jan-2024 MetrioPharm Publishes First Trial Data Showing Effects of Host-Directed Therapy in COVID-19 MetrioPharm
31-Jan-2024 New investigator-initiated clinical trials of BellaSeno´s resorbable tissue regeneration scaffolds to be conducted in Europe BellaSeno GmbH
30-Jan-2024 Huxley Health Inc. Provides Corporate Update - Appoints Bruce Linton as Chairman Huxley Health Inc
30-Jan-2024 ABPI welcomes Labour's life sciences plan ABPI
30-Jan-2024 Fabentech awarded €7.7m from the European Commission as coordinator of the e FabRIC consortium to develop an innovative broad-spectrum therapy against emerging viruses with pandemic potential Fabentech
30-Jan-2024 Axplora invests €8 million in Le Mans to further expand its capacity for antibody drug conjugate manufacturing Axplora